About Us

OPTIMIZED BY EVOLUTION

Wugen is developing off-the-shelf cellular therapies for cancer

Our cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML) and T-cell malignancies.

At Wugen, we are developing off-the-shelf:

  • NK cell therapies targeting solid tumors and hematologic malignancies
  • CAR-T cell therapies targeting T-cell malignancies
Our issued and pending patents support and protect a strong pipeline of convenient, off-the-shelf therapies that are developed to treat patients with cancer.
AdobeStock_305639539-1.jpg
AdobeStock_305639539-1.jpg
ST. LOUIS

4260 Forest Park Ave
Suite 100
St. Louis, MO 63108
(636) 385-5306

SAN DIEGO

9880 Campus Point Dr
Suite 430
San Diego, CA 92121

SOCIAL

Copyright © 2024 Wugen. All Rights Reserved.

Privacy Notice

a COGNEO design